Meal Tolerance Trial in Pregnant Women Diagnosed With Gestational Diabetes Mellitus.
NCT02225951 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3
Last updated 2017-09-07
Summary
This study is initiated to investigate the effect of a nutritional product on the 3-hr postprandial glucose response compared to a control standard breakfast at baseline and after 4 weeks of intervention.
Conditions
- Gestational Diabetes Mellitus in Pregnancy
Interventions
- DIETARY_SUPPLEMENT
-
Nutritional product
- OTHER
-
Standard breakfast according to ADA recommendations
Sponsors & Collaborators
-
Nutricia Research
collaborator INDUSTRY -
Danone Asia Pacific Holdings Pte, Ltd.
lead INDUSTRY
Principal Investigators
-
Kok Hian Tan, MBBS · KKH
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-07-31
- Primary Completion
- 2014-09-30
- Completion
- 2014-09-30
Countries
- Singapore
Study Locations
More Related Trials
-
Effects of a Small Protein and Lipid Preload on Glucose Tolerance in Subjects With Impaired Glucose Homeostasis
NCT02342834 ·Status: COMPLETED ·Phase: NA
-
Characterization of the Variability Of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Prediabetes
NCT01663207 ·Status: COMPLETED
-
Low-dose Dasiglucagon for Prevention of Insulin-Induced Hypoglycemia in People With Type 1 Diabetes
NCT04449692 ·Status: COMPLETED ·Phase: PHASE2
-
The Role of Pregnancy-induced Gallbladder Dysmotility in the Pathophysiology of Gestational Diabetes Mellitus
NCT04108065 ·Status: COMPLETED
-
Drug Trial of Lixisenatide on Gastric Emptying and Blood Pressure Drops in Type 2 Diabetics and Healthy People
NCT02308254 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1
NCT01773707 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis
NCT03544229 ·Status: COMPLETED ·Phase: PHASE2
-
Postprandial Gut Hormone Responses in Patients With Type 1 Diabetes Mellitus
NCT04430946 ·Status: UNKNOWN ·Phase: NA
-
A Study to Evaluate the Effect of Fasting Duration and Dulaglutide (LY2189265) Withholding on Gastric Retention in Participants With Type 2 Diabetes Mellitus
NCT07313813 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Trial of IW-9179 in Patients With Diabetic Gastroparesis (DGP)
NCT02289846 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Effect of Taspoglutide on Gastric Emptying in Patients With Type 2 Diabetes
NCT00809705 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Physiologic Mixed Meal Tolerance
NCT04532801 ·Status: WITHDRAWN ·Phase: PHASE1
-
Effect of Medically-tailored Meal Delivery Service on Changes in Hemoglobin A1c (HbA1c) in Patients With Diabetes
NCT04523155 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Once-daily Oral Administrations of TZP-102 for Gastroparesis in Patients With Diabetes Mellitus
NCT00889486 ·Status: COMPLETED ·Phase: PHASE2
-
Endogenous Glucoseproduction in Patients With Type 2 Diabetes Mellitus During Oral Glucose and iv. Glucose Infusion
NCT02010827 ·Status: COMPLETED
-
Current Status of Islet Alpha Cell Function in Patients with Type 2 Diabetes
NCT06825182 ·Status: RECRUITING ·Phase: PHASE3
-
A Trial to Compare the PK and PD of Insulin Lispro Administered Into Different Tissues in Subjects With Diabetes Mellitus Type 1
NCT02221323 ·Status: COMPLETED ·Phase: PHASE2
-
Study About Adherence and Tolerance of an Oral Nutritional Supplement (ONS) Specific for Diabetic Patient.
NCT05488210 ·Status: UNKNOWN
-
Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy
NCT02262832 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Effect of TAK-954 on Gastrointestinal and Colonic Transit in Diabetic or Idiopathic Gastroparesis Participants
NCT03281577 ·Status: COMPLETED ·Phase: PHASE2
-
GA 6: The Blood Glucose-lowering Effect of Glucose-dependent Insulinotropic Polypeptide
NCT03845179 ·Status: COMPLETED ·Phase: NA
-
Comparison of Enteral Products for Tube Fed Patients With Type 2 Diabetes
NCT00544206 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Nateglinide on Postprandial Glucose Excursion by Restoring Early Phase Insulin Secretion
NCT01030952 ·Status: COMPLETED ·Phase: PHASE4
-
An Efficacy and Safety Study of Cisapride for Improving Symptoms Associated With Gastroparesis in Patients With Diabetes Mellitus
NCT01286090 ·Status: TERMINATED ·Phase: PHASE4
-
Insulin Resistance and Vessel Function After Meals: Does Early Intervention Make a Difference?
NCT00259168 ·Status: COMPLETED ·Phase: PHASE4